New Zealand Building Stock News

Summerset Group Holdings recently held an Analyst/Investor Day to provide a performance update, focusing on business conditions following the late-February Middle East conflict. The company’s decision to directly address geopolitical risks and their operational implications offered investors rare, real-time insight into management’s response framework. We will now examine how Summerset’s conflict-related performance update shapes its investment narrative, particularly around risk management...

We'd be surprised if Scales Corporation Limited ( NZSE:SCL ) shareholders haven't noticed that the Chief Financial...

Why Meridian Energy’s index inclusion matters for investors Meridian Energy (NZSE:MEL) has been added to the S&P Dow Jones Best-in-Class World Index, placing it among the top 10% of global utilities for governance, ESG transparency, and organisational resilience. This recognition, and Meridian’s position as the only New Zealand company in the index, has drawn fresh attention to the stock and its longer term approach to managing climate and demand pressures in energy markets. See our latest...

In the midst of geopolitical tensions and fluctuating energy prices, global markets have experienced a mixed performance with large-cap stocks outpacing their small-cap counterparts. Despite these challenges, the Russell 2000 Index has shown resilience with a year-to-date increase of over 13%, highlighting potential opportunities within the small-cap sector. In this environment, identifying promising small-cap stocks often involves looking for companies that demonstrate strong fundamentals...

Gentrack Group (NZSE:GTK) is back in focus after a trading update that lowered FY 2026 revenue guidance, triggered a sharp share price drop, and outlined a share buyback along with a renewed push into recurring revenue. See our latest analysis for Gentrack Group. The share price reaction has been sharp, with a 7 day share price return of 34.49% decline and a year to date share price return of 53.25% decline. However, the 5 year total shareholder return of 150% is still positive, suggesting...

Contract announcement puts Infratil in focus Infratil (NZSE:IFT) has drawn fresh investor attention after announcing a new contract and scheduling a special call to explain how the agreement could influence its future revenue profile and operations. See our latest analysis for Infratil. The contract announcement sits alongside strong recent share price momentum, with a 1 day share price return of 13.23% and a 30 day share price return of 26.74%, while the 5 year total shareholder return of...

Meridian Energy was recently added to S&P Dow Jones’ Best-in-Class World Index, placing it among the top 10% of utilities worldwide for organisational resilience, governance, and ESG transparency. As the only New Zealand company in this index, Meridian’s inclusion highlights its distinct position in global sustainability benchmarks and its appeal to ESG-focused stakeholders. We’ll now examine how Meridian’s Best-in-Class World Index status may influence its investment narrative around ESG...

Wondering if Fisher & Paykel Healthcare, at around its recent price of $35.75, is offering fair value or if you would be overpaying for growth potential. The stock has been relatively muted in the short term, with returns of 1.1% over the last year, a 5.1% decline year to date, and smaller pullbacks of 1.4% over 7 days and 2.6% over 30 days. These moves have kept Fisher & Paykel Healthcare on many watchlists, as investors weigh its long term track record of 40.7% over 3 years and 17.0% over...

In early May 2026, The a2 Milk Company voluntarily recalled three batches of its imported a2 Platinum Premium USA label infant formula sold in the United States after detecting cereulide, a heat‑stable toxin, advising customers to stop using the product and return it for a refund, despite no confirmed illnesses. An interesting aspect is that the affected infant formula line had already been discontinued and removed from sale before the recall, raising questions about how a past quality issue...

Analyst and investor day puts recent geopolitical risks in focus Summerset Group Holdings (NZSE:SUM) held an Analyst and Investor Day to update the market on how operations and performance are tracking after the outbreak of conflict in the Middle East at the end of February. See our latest analysis for Summerset Group Holdings. At a share price of NZ$8.04, the stock has faced a 30.0% 3-month share price return decline and a 35.1% year-to-date share price return decline, while the 3-year total...

Auckland International Airport (NZSE:AIA) is back in focus after CEO Carrie Hurihanganui publicly raised concerns about aviation competition in New Zealand and reported a 15% rise in aeronautical revenues following the end of a Covid-era price freeze. See our latest analysis for Auckland International Airport. At a share price of NZ$8.37, Auckland International Airport has recorded a 1 day share price return of 1.45% and a 30 day share price return of 3.72%, while the 1 year total shareholder...

Recent projections for strong growth in China’s baby food market, driven by higher disposable incomes, urbanization, and a rising focus on infant nutrition, put a2 Milk (NZSE:ATM) firmly in the spotlight as one of the sector’s key players. See our latest analysis for a2 Milk. a2 Milk’s share price has recently been under pressure, with a 30 day share price return of 20.18% decline and a year to date share price return of 17.13% decline, even as the 3 year total shareholder return sits at...

Fisher & Paykel Healthcare (NZSE:FPH) is back in focus after recent share price moves, with the stock showing a 0.7% decline over the past day and softer returns over the past month. See our latest analysis for Fisher & Paykel Healthcare. While the 1-day share price return of 0.72% and 7-day share price return of 5.80% point to softer short term momentum, the 1-year total shareholder return of 5.57% and 3-year total shareholder return of 34.95% indicate that longer term holders have still...

Genesis Energy has confirmed it reached a Final Investment Decision on 17 April 2026 for Stage 2 of its Battery Energy Storage System at Huntly Power Station, committing roughly NZ$106 million to add 100MW / 200MWh of consented, grid-connected capacity by the third quarter of fiscal 2028. This expansion, funded on balance sheet after a recent NZ$400 million equity raise, is positioned as New Zealand’s lowest-cost committed grid-scale BESS to date and a key milestone in Genesis’ Gen35 growth...

Genesis Energy (NZSE:GNE) has committed to a second stage of battery storage at Huntly Power Station, approving a 100MW / 200MWh expansion that supports its Gen35 plan and shift away from baseload gas. See our latest analysis for Genesis Energy. The Huntly BESS expansion comes as Genesis Energy’s 1 month share price return of 8.8% and 7 day return of 4.4% contrast with a year to date share price decline of 2.1%. At the same time, the 1 year total shareholder return of 17.1% and positive 3...

Readers hoping to buy Scott Technology Limited ( NZSE:SCT ) for its dividend will need to make their move shortly, as...

As Asian markets navigate a landscape marked by geopolitical developments and economic data releases, small-cap stocks are capturing attention with their potential for growth amid broader market movements. In this context, insider buying can serve as a valuable indicator of confidence in these companies' prospects, offering insights into which stocks might be positioned to capitalize on current conditions.

Ryman Healthcare Limited reported that total sales of occupation right agreements for retirement village units rose to 331 in the fourth quarter ended 31 March 2026, up from 302 a year earlier. This lift in quarterly unit sales points to firmer demand for Ryman’s retirement village offering, an important indicator for ongoing village occupancy and cash generation. We’ll now examine how this stronger fourth-quarter unit sales performance shapes Ryman Healthcare’s investment narrative and...

Ryman Healthcare (NZSE:RYM) has drawn investor attention after reporting fourth quarter sales of 331 occupation right agreements for retirement village units, compared with 302 a year earlier, in its latest trading statement. See our latest analysis for Ryman Healthcare. The trading update comes after a mixed run in the share price, with a 3.98% 1 day share price return and a 0.97% 7 day share price return, set against a 27.93% 90 day share price decline and a 57.76% 3 year total shareholder...

Why Fonterra’s CEO Change Matters For Shareholders Fonterra Co-operative Group (NZSE:FCG) has announced that long-time executive Richard Allen will become CEO on May 1, 2026, with outgoing chief Miles Hurrell staying on as an adviser until September. This internal appointment, following Allen’s senior roles across ingredients, foodservice, Farm Source and international operations, keeps attention on how leadership continuity might influence Fonterra’s scale, capital allocation and dividend...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Scott Technology (NZSE:SCT) H1 2026 earnings snapshot Scott Technology (NZSE:SCT) has reported fresh numbers for H1 2026, with revenue of NZ$153.5 million and basic EPS of NZ$0.119, alongside net income of NZ$10.0 million. Over recent halves the company recorded revenue of NZ$135.3 million in H2 2024, NZ$121.7 million in H1 2025 and NZ$153.5 million in H2 2025. Over the same periods, basic EPS moved from NZ$0.0418 to NZ$0.054 and then to NZ$0.119, making this release a useful check on how...

We feel now is a pretty good time to analyse Serko Limited's ( NZSE:SKO ) business as it appears the company may be on...

Warehouse Group (NZSE:WHS) has just posted its H1 2026 scorecard, with trailing twelve month revenue of NZ$3.1b and basic EPS of NZ$0.003, while the latest reported half year, H2 2025, showed revenue of NZ$1,479.5 million and a net income loss of NZ$14.6 million. Over recent halves, revenue has moved from NZ$1,404.9 million in H2 2024 to NZ$1,607.2 million in H1 2025 and then to NZ$1,479.5 million in H2 2025, with EPS swinging between a loss of NZ$0.074, a profit of NZ$0.034, and a loss of...